Reversible epigenetic alterations regulate class I HLA loss in prostate cancer
Tamara S. Rodems(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison)
Cited by 52
Related Papers
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
|Clinical Cancer Research|2023|52